choline has been researched along with Lymphoma, Non-Hodgkin in 7 studies
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Abeykoon, JP | 1 |
Wu, X | 1 |
Nowakowski, KE | 1 |
Dasari, S | 1 |
Paludo, J | 1 |
Weroha, SJ | 1 |
Hu, C | 1 |
Hou, X | 1 |
Sarkaria, JN | 1 |
Mladek, AC | 1 |
Phillips, JL | 1 |
Feldman, AL | 1 |
Ravindran, A | 1 |
King, RL | 1 |
Boysen, J | 1 |
Stenson, MJ | 1 |
Carr, RM | 1 |
Manske, MK | 1 |
Molina, JR | 1 |
Kapoor, P | 1 |
Parikh, SA | 1 |
Kumar, S | 1 |
Robinson, SI | 1 |
Yu, J | 1 |
Boughey, JC | 1 |
Wang, L | 1 |
Goetz, MP | 1 |
Couch, FJ | 1 |
Patnaik, MM | 1 |
Witzig, TE | 1 |
Kowa, JY | 1 |
Millard, T | 1 |
Goldman, A | 1 |
Sharma, RK | 1 |
Attygalle, A | 1 |
Mahalingam, P | 1 |
Marshall, K | 1 |
Welsh, L | 1 |
Li, S | 1 |
Mackinnon, A | 1 |
Rich, P | 1 |
Nicholson, E | 1 |
Iyengar, S | 1 |
El-Sharkawi, D | 1 |
Chau, I | 1 |
Cunningham, D | 1 |
Sharma, B | 1 |
Ribeiro, TH | 1 |
S, R | 1 |
Castro, AC | 1 |
Paulino, E | 1 |
Mamede, M | 1 |
Li, LF | 1 |
Taw, BB | 1 |
Pu, JK | 1 |
Hwang, GY | 1 |
Lui, WM | 1 |
Leung, GK | 1 |
Lee, SC | 1 |
Poptani, H | 1 |
Pickup, S | 1 |
Jenkins, WT | 1 |
Kim, S | 1 |
Koch, CJ | 1 |
Delikatny, EJ | 1 |
Glickson, JD | 1 |
Duyn, JH | 1 |
Frank, JA | 1 |
Moonen, CT | 1 |
Bizzi, A | 1 |
Movsas, B | 1 |
Tedeschi, G | 1 |
Phillips, CL | 1 |
Okunieff, P | 1 |
Alger, JR | 1 |
Di Chiro, G | 1 |
7 other studies available for choline and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Checkpoints; Choline; DNA Repair | 2021 |
Are treatment response assessment maps (TRAMs) and
Topics: Central Nervous System Neoplasms; Cerebellar Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxy | 2021 |
Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT.
Topics: Choline; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neop | 2017 |
Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings.
Topics: Adult; Central Nervous System Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Glioma; Humans; Ki | 2015 |
Early detection of radiation therapy response in non-Hodgkin's lymphoma xenografts by in vivo 1H magnetic resonance spectroscopy and imaging.
Topics: Animals; Choline; Humans; Lactic Acid; Lipid Metabolism; Lymphoma, Non-Hodgkin; Magnetic Resonance I | 2010 |
Incorporation of lactate measurement in multi-spin-echo proton spectroscopic imaging.
Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Humans; Image Processing, | 1995 |
Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging.
Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Female; Follow-Up Studies; Humans; Lipid Metaboli | 1995 |